Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 1,591.50
+8.50 (0.54%)
Oct 9, 2026, 3:30 PM JST
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of 713.94 billion as of October 9, 2026. It is the 3,949th most valuable company in the world and the 270th biggest in Japan. Its market cap has decreased by 4.31% in one year.
Market Cap
713.94B
Enterprise Value
797.95B
Revenue
474.79B
Global Rank
Country Rank
#270 Japan
PE Ratio
5.75
ChartMarket Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 713.94B, an increase of 246.69%. That is a compound annual growth rate of 3.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 713.94B | -22.48% |
| Dec 30, 2025 | 920.92B | 311.72% |
| Dec 30, 2024 | 223.67B | 20.82% |
| Dec 29, 2023 | 185.14B | -53.35% |
| Dec 30, 2022 | 396.90B | -24.60% |
| Dec 30, 2021 | 526.41B | -13.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shionogi & | 2.35T |
| Eisai | 1.31T |
| Tsumura & Co. | 278.95B |
| Nippon Shinyaku | 226.33B |
| Sawai Group Holdings | 186.37B |
| Towa Pharmaceutical | 174.27B |
| Kissei Pharmaceutical | 152.89B |
| Kaken Pharmaceutical | 141.44B |